Jingcheng Huang1, Chengshi Hou1, Qingqing Wen2, Weiqiang Dou2, and Xianfu Luo1
1Clinical Medical School of Yangzhou University, Northern Jiangsu People’s Hospital, Yangzhou, China, Yangzhou City, China, 2GE Healthcare, MR Research China, Beijing, P.R. China, Beijing City, China
Synopsis
Keywords: Quantitative Imaging, CEST & MT, APTw
Conventional MRI methods are difficult to
reveal histologic and molecular characteristic of HCC. In this study, we aimed
to e explore the feasibility of amide proton transfer weighted (APTw) imaging for
predicting microvascular invasion (MVI) of hepatocellular carcinoma.
Significant difference in APTw values were observed for MVI positive and
negative lesions. With these findings, APTw imaging can be considered a
potential technique for noninvasive preoperational assessment of MVI in
hepatocellular carcinoma.
Introduction
Hepatocellular carcinoma (HCC) is the
fastest rising cause of cancer-related death worldwide. Surgical resection and
liver transplantation remain as the first-choice treatments for patients with
early-stage HCC. MVI mainly appears as small thrombi of malignant cells in the
portal and hepatic venous systems. And MVI had been demonstrated as a strong
risk factor associated with recurrence and survival among HCC patients after
resection[1]. However, currently, MVI can only be reliably
determined by histopathologic evaluation of surgical specimens.
Amide
proton transfer weighted (APTw) imaging, as a branch of chemical exchange
saturation transfer (CEST) imaging, focuses on proton exchange between amide
protons of peptides and proteins and bulk water[2,3].
Two recent studies showed the potential of APTw imaging in predicting the
histologic grades of HCC[4,5]. Moreover,
some histological differentiation of HCC had strong relationship with MVI, in
other words, MVI was more easily presented in patients with worse histological
differentiation. With
these applications, we hypothesized that APTw imaging may help to assess the MVI of HCC.Materials and Methods
Subjects
The study
was approved by local ethical community and consent forms were obtained from
all patients. 32 patients histologically confirmed HCC were enrolled in the
study. MVI was pathologically confirmed from tumor resection including 13 cases
with MVI (MVI+) and 15 without MVI (MVI−).
MRI
experiments
All patients underwent liver MR scanning on
a 3.0-tesla scanner (GE DISCOVERY MR750; Milwaukee, Wisconsin, USA) with a
32-channel phased-array torso coil. All patients underwent fasting 4-6 hours
before examination. Liver tumor scan protocol was used including routine T2
weighted imaging, T1 weighted imaging, diffusion-weighted imaging.
Before contrast injection, APTw imaging was
performed with a respiratory triggered single slice Spin-echo echo-planar-imaging sequence. Images at 52
frequencies were acquired, including 49 frequencies ranging from -600 to 600 Hz
with an increment of 25 Hz. The applied saturation B1 power was 2µt and the
saturation duration was 2000ms. Other scan parameters were of TE=32.7ms, TR=5432ms,
FOV=34cm × 26 cm, Matrix size=128 × 128, and slice thickness=8mm. Scan time was
around 2 minutes 52 seconds.
Imaging
analysis
Magnetization transfer ratio asymmetry (MTRasym)
image at 3.5ppm was obtained for each patient. Two radiologists with 5 and 13 experiences
were employed for data analysis. With the reference of axial T2WI
images, three circular regions of interest (ROIs) with approximately 40-50mm2 were placed manually in the solid component of the tumor for each
patient on unsaturated M0 images. Large cystic cavities, large areas
of necrosis, calcification, hemorrhage, and large vessels were excluded from
ROI selections. ROIs of tumors were copied on the MTRasym map. Then
the average APTw in the three ROIs for each radiologist was obtained for
subsequent analyses.
Statistical
analysis
All statistical analyses were performed in
SPSS 23.0. The inter-class correction coefficient (ICC) was used to evaluate
the inter-observer agreement of measuring APTw value between two radiologists.
ICC>0.75 was considered good reproducibility. The comparisons between APTw
value for MVI-
and MVI+ groups were analyzed using the independent t
test. Receiver operating characteristic (ROC) curves were generated for each
APTw parameter value to assess the areas under the curve (AUC).
Results
The ICC of two observers’ measurements was
0.912. The APTw value of MVI+ group was significantly higher than that of MVI−
group [ (1.33±0.76) % vs (0.32±1.06) %; P=0.008] (Fig. 1). The cut-off APTw value for
differentiating MVI+ and MVI− groups was 0.30% (sensitivity, 60%; specificity, 100%;
AUC, 0.782, 95%CI: 0.609, 0.955). Representative cases are shown in Fig. 2 and Fig. 3.Discussion and conclusions
Our study showed that the APTw value of MVI+ group is significantly higher than MVI- group. Hepatocellular carcinoma with microvascular invasion tends to be more malignant and has more mobile proteins and may have a higher proliferation of hepatocellular carcinoma cells, greater cell density, which leads to the higher value of APTw.
In conclusion, this study showed promising ability in differentiating MVI+ and MVI− HCC. Follow-up studies with larger patient cohort are needed to further validate its diagnostic performance.Acknowledgements
We thank
Weiqiang Dou from GE Healthcare for this valuable support on APT sequences.References
1 Du M,
Chen L, Zhao J, et al. Microvascular invasion (MVI) is a poorer prognostic
predictor for small hepatocellular carcinoma. BMC Cancer.
2014;14:38.
2 Zhou J,
Payen JF, Wilson DA, Traystman RJ, van Zijl PC. Using the amide proton signals
of intracellular proteins and peptides to detect pH effects in MRI. Nat
Med. 2003;9(8):1085-1090.
3 Zhou J,
Lal B, Wilson DA, Laterra J, van Zijl PC. Amide proton transfer (APT) contrast
for imaging of brain tumors. Magn Reson Med. 2003;50(6):1120-1126.
4 Wu B,
Jia F, Li X, Zhang M, Han D, Jia Z. Amide Proton Transfer Imaging vs Diffusion
Kurtosis Imaging for Predicting Histological Grade of Hepatocellular
Carcinoma. J Hepatocell Carcinoma. 2020;7:159-168.
5 Lin Y,
Luo X, Yu L, et al. Amide proton transfer-weighted MRI for predicting histological
grade of hepatocellular carcinoma: comparison with diffusion-weighted
imaging. Quant Imaging Med Surg. 2019;9(10):1641-1651.